| IXEMPLE A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY Bristol-Myers Squibb Company
77760937 31 Dec 1969 | on 19 Jun 2009 | Medical and scientific research, namely, conducting clinical trials an... Class 042 Class 042 Computer & Software Services & Scientific Services Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use | | | IXEMPLE A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY Bristol-Myers Squibb Company
77775355 31 Dec 1969 | on 13 Jul 2009 | Medical and scientific research, namely, conducting clinical trials an... Class 042 Class 042 Computer & Software Services & Scientific Services Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use | | | IXAMPLE A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY Bristol-Myers Squibb Company
77775341 31 Dec 1969 | on 10 Jul 2009 | Medical and scientific research, namely, conducting clinical trials an... Class 042 Class 042 Computer & Software Services & Scientific Services Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use | | | IXAMPLE A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY Bristol-Myers Squibb Company
77760923 31 Dec 1969 | on 19 Jun 2009 | Medical and scientific research, namely, conducting clinical trials an... Class 042 Class 042 Computer & Software Services & Scientific Services Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use | | | IVORY A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY Bristol-Myers Squibb Company
77762649 31 Dec 1969 | on 24 Jun 2009 | Medical and scientific research, namely, conducting clinical trials an... Class 042 Class 042 Computer & Software Services & Scientific Services Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use | | | CANADIAN FARM & HOME ALMANAC FOR THE YEAR OF OUR LORD BEING BISSEXTILE, OR LEAP YEAR, AND UNTIL THE FIRST OF JULY THE YEAR OF CONFEDERATION CONTAINING BITS OF LOGIC, FORMULAS FOR GOOD COOKERY, WEATHER PROGNOSTICATIONS, HUMOR, POETRY AND ODDS AND ENDS DESIGNED FOR YOUR ENJOYMENT AND EDIFICATION GEIGER, ANNA HUEBER
73573436 16 Dec 1985 | on 30 Aug 1993 | ALMANAC,ALMANAC Class 016 Class 016 Paper Goods and Printed Material 1ST OF JULY THE YEAR OF THE CONFEDERATION | | | BUTTER BROAD TYPES PRIMARY CHARACTERISTICS SECONDARY IMPACT FUNCTION SAVORY CREAMY CULTURED SWEET TOASTED TANGY GRASSY SALTY MILKY YEASTY FERMENTED FRUITY BARNYARD ANIMAL BROWN COOKED POPCORN-LIKE FATTY INDULGENT MELTED RICH MASKING BUILDER MOUTHFEEL REPLACER HEAT TOLERANT The Edlong Corporation
87942765 31 May 2018 | on 27 Jun 2019 | custom manufacture of food flavorings and food products,custom manufac... Class 040 Class 040 Treatment & Processing of Materials Services custom manufacture of food flavorings and food products | | | ASPARAHOPS . ALL WORDS, PHOTOS, MARKETING, ADVERTISEMENT OR ART WORK DEPICTING THE HUMULUS LUPULUS PLANT'S NEW SPRING GROWTH SHOOTS BEING CUT, BUNDLED OR COOKED FOR CONSUMPTION AS A VEGETABLE AND MARKETED AS SIMILAR IN SHAPE, FLAVOR OR COOKING STYLE AS ASPARAGUS AND INCLUDING THE WORD 'HOP' OR 'HOPS' INTO THE DESCRIPTION OR NAME. Coryell, Emily Marilla
88372251 31 Dec 1969 | on 23 Apr 2019 | Unprocessed hops; asparahops hops; asparagus hops shoots hops; hops sp... Class 031 Class 031 Natural Agricultural Products The name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual. | | | BROAD MILK CREAM TYPES (FAT %) PRIMARY CHARACTERISTICS SECONDARY IMPACT FUNCTION SKIM | 1% | 2% WHOLE (3%) HALF AND HALF LIGHT CREAM HEAVY CREAM CLOTTED CREAM SOUR | BUTTERY | CULTURED GRASS-FED STEAMED FERMENTED | FRESH | SWEET | COOKED SWEETENED CONDENSED SMOOTH | INDULGENT RICH MASKING BUILDER MOUTHFEEL REPLACER HEAT TOLERANT The Edlong Corporation
87942809 31 May 2018 | on 27 Jun 2019 | custom manufacture of food flavorings and food products,custom manufac... Class 040 Class 040 Treatment & Processing of Materials Services The mark consists of a flavor wheel consisting of concentric circles separated into four triangular sections with the three smaller triangular sections each separated by a line, and all of which meet in the center of the innermost circle. The innermost circle contains the wording "MILK & CREAM". The space between the outermost two concentric circles at the top of the left triangular section is the wording "BROAD MILK /CREAM TYPES (FAT %)" above the wording "Skim", "1%" and "2%" with a line separating the terms, stacked above the wording "Whole" "(3%)", stacked above the wording "Half and Half", stacked above the wording "Light Cream", stacked above the wording "Heavy Cream", stacked above the wording "Clotted Cream". The space between the outermost two concentric circles at the top of the middle triangular section is the wording "PRIMARY CHARACTERISTICS" above the wording "Sour" "Buttery" "Cultured" with a line separating the terms, stacked above the wording "Grass-fed" "Steamed" with a line separating the terms, stacked above the wording "Fermented" "Fresh" with a line separating the terms, stacked above the wording "Sweet" "Cooked" with a line separating the terms, stacked above the wording "Sweetened" stacked above the wording "Condensed". The space between the outermost two concentric circles at the top of the right triangular section is the wording "SECONDARY IMPACT" above the wording "Smooth" "Indulgent" with a line separating the terms, stacked above the word "Rich". The fourth triangular section extends beyond the concentric circles and contains a pitcher of milk set upon a wooden table. Within the fourth triangular section are five small circles. The top left small circle is super-imposed over the pitcher and contains an outline of an eye mask with the wording "Masking" below it. The top right small circle contains outlines of three squares stacked above the wording "Builder". The bottom left small circle is super-imposed over the pitcher and contains an outline of a mouth with an outline of fork tines directly underneath and to the right with the wording "Mouthfeel" to the left. The bottom middle small circle is partially super-imposed over the pitcher and contains an outline of a triangle and to the left of the triangle an outline of an arrow pointing downward above an outline of a circle next to an outline of an arrow pointing upward, all above the wording "Replacer". The bottom right small circle contains an outline of a flame above the wording "Heat Tolerant". The space between the outermost two concentric circles at the bottom of the fourth triangular section is the wording "FUNCTION". The shaded areas are intended to show contrast only. | | | ASIDE: A PHASE IIIB, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY AND INTRAVENOUSLY IN SUBJECTS WITH RHEUMATOID ARTHRITIS, RECEIVING BACKGROUND METHOTREXATE, AND EXPERIENCING AN INADEQUATE RESPONSE TO METHOTREXATE Bristol-Myers Squibb Company
85063047 15 Jun 2010 | on 12 Aug 2013 | Medical and scientific research, namely, conducting clinical trials re... Class 042 Class 042 Computer & Software Services & Scientific Services "A PHASE IIIB, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY AND INTRAVENOUSLY IN SUBJECTS WITH RHEUMATOID ARTHRITIS, RECEIVING BACKGROUND METHOTREXATE, AND EXPERIENCING AN INADEQUATE RESPONSE TO METHOTREXATE" | |